SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-20-030827
Filing Date
2020-03-09
Accepted
2020-03-09 17:12:36
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 a20-11790_1s3.htm S-3 446513
2 EX-1.2 a20-11790_1ex1d2.htm EX-1.2 239220
3 EX-5.1 a20-11790_1ex5d1.htm EX-5.1 35356
4 EX-23.1 a20-11790_1ex23d1.htm EX-23.1 3456
5 GRAPHIC g117901ksi001.gif GRAPHIC 2963
6 GRAPHIC g117901bki001.jpg GRAPHIC 5325
7 GRAPHIC g117901bmi001.jpg GRAPHIC 32155
8 GRAPHIC g117901bqi001.jpg GRAPHIC 5822
9 GRAPHIC g117901bei001.jpg GRAPHIC 5822
  Complete submission text file 0001104659-20-030827.txt   797990
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-237040 | Film No.: 20698816
SIC: 2834 Pharmaceutical Preparations